Armata Pharmaceuticals (ARMP) Enterprise Value (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Enterprise Value of -$4.8 million for Q1 2026, up 44.75% sequentially from -$8.7 million in Q4 2025, and up 58.93% YoY from -$3.0 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Enterprise Value (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Enterprise Value for 14 years, with the latest figure at -$4.8 million in Q1 2026.
- Quarterly Enterprise Value rose 58.93% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 58.93% YoY) and the FY2025 annual result came in at -$8.7 million, up 6.49% from the prior year.
- Enterprise Value grew to -$4.8 million in Q1 2026 per ARMP's latest filing, from -$8.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$4.3 million in Q2 2025 and troughed at -$46.4 million in Q1 2022.
- A 5-year average of -$19.6 million and a median of -$14.9 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 111.99% in 2024, then jumped 83.61% in 2025.
- Over 5 years, Enterprise Value stood at -$14.9 million in 2022, then rose by 8.95% to -$13.5 million in 2023, then soared by 31.29% to -$9.3 million in 2024, then increased by 6.49% to -$8.7 million in 2025, then surged by 44.75% to -$4.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$4.8 million, -$8.7 million, and -$14.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | -24.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.00 Mn |
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -8.69 Mn |
| Sep 30, 2025 | -14.76 Mn |
| Jun 30, 2025 | -4.33 Mn |
| Mar 31, 2025 | -11.69 Mn |
| Dec 31, 2024 | -9.29 Mn |
| Sep 30, 2024 | -17.14 Mn |
| Jun 30, 2024 | -26.41 Mn |
| Mar 31, 2024 | -37.86 Mn |
| Dec 31, 2023 | -13.52 Mn |
| Sep 30, 2023 | -23.96 Mn |
| Jun 30, 2023 | -12.46 Mn |
| Mar 31, 2023 | -25.11 Mn |
| Dec 31, 2022 | -14.85 Mn |
| Sep 30, 2022 | -25.38 Mn |
| Jun 30, 2022 | -36.98 Mn |
| Mar 31, 2022 | -46.41 Mn |
| Dec 31, 2021 | -10.29 Mn |
| Sep 30, 2021 | -12.08 Mn |